Rejin Kebudi
Overview
Explore the profile of Rejin Kebudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
1258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yildirim U, Kebudi R, Zulfikar B, Bilgic B
Turk J Pediatr
. 2025 Mar;
67(1):51-60.
PMID: 40084721
Background: Inflammatory myofibroblastic tumors (IMTs) are rare neoplasms in children. Traditionally, surgical resection has been the primary treatment modality with limited efficacy reported for conventional chemotherapy and radiation therapy. Recently,...
2.
Aydin A, Bingol H, Kebudi R, Savas E, Koc B, Buyukkapu Bay S, et al.
J Relig Health
. 2025 Jan;
PMID: 39865191
Perceptions of death can greatly impact the ability to cope with grief, making it either easier or unbearable. Research on the importance of religion and spirituality in the field of...
3.
Yildirim U, Kebudi R, Iribas Celik A, Zulfikar B, Kebudi A
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860595
Childhood cancer survival rates have improved, but survivors face an increased risk of second malignant neoplasms (SMNs), particularly thyroid cancer. This study examines the demographic, clinical, genetic, and treatment characteristics...
4.
Kebudi R, Koca D, Yildirim U
Curr Pediatr Rev
. 2025 Jan;
PMID: 39757638
Introduction: Neuroblastoma is the most common extracranial solid tumor found in childhood. Case Representation: Primary renal neuroblastoma has been reported in the literature as case reports. Almost all cases had...
5.
Yildirim U, Kebudi R, Dalkilic Bingol H, Koc Senol B, Zulfikar B
Turk Arch Pediatr
. 2024 Nov;
59(6):543-546.
PMID: 39540724
Objective: Increased survival rates in childhood cancer have led to an emphasis on the importance of treatment-related infertility. Fertility preservation methods should be explained to every patient and their families...
6.
Kacar D, Kebudi R, Ozyoruk D, Tugcu D, Bahadir A, Ozdemir Z, et al.
Turk J Pediatr
. 2024 Oct;
66(4):401-411.
PMID: 39387429
Background: Microbiologic confirmation of respiratory tract infections gained importance during the coronavirus disease 2019 (COVID-19) pandemic. This study retrospectively evaluated seasonal distribution, clinical presentation, and complications of respiratory viral infections...
7.
Kebudi R, Yildirim U, Iribas A, Tuncer S
Pediatr Blood Cancer
. 2024 Sep;
71(12):e31337.
PMID: 39344026
Background: Optic pathway gliomas (OPG) are rare tumors in children. Lesion extent, visual functions, neurofibromatosis 1 (NF1), and age are factors that guide treatment. This study evaluates the clinical characteristics,...
8.
Khodzhaev K, Sudutan T, Erbilgin Y, Saritas M, Yegen G, Bozkurt C, et al.
Eur J Med Genet
. 2024 Sep;
72:104975.
PMID: 39322061
Hodgkin's lymphoma (HL) is the most common cancer in adolescents and young adults. A family history of HL increases the risk of developing HL in other family members. Identification of...
9.
Mandala M, Ferrari A, Brecht I, Suijkerbuijk K, Maschke L, Giannarelli D, et al.
Eur J Cancer
. 2024 Sep;
211:114305.
PMID: 39236557
Background: Data on the efficacy and safety of anti PD-1 antibodies in children and adolescents (CA) with melanoma are lacking. The aim of this study was to determine outcomes of...
10.
Yildirim U, Koca D, Kebudi R
Turk J Pediatr
. 2024 Jul;
66(3):332-339.
PMID: 39024601
Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare in children and adolescents. Standard management of these tumors has not been well established due to their rarity in this age group. We...